bioAffinity Technologies (BIAF) vs XWELL (XWEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
XWELL is the larger company by market cap ($8.2 million vs $6.1 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | XWEL |
|---|---|---|
| Share price | $4.73 | $0.8215 |
| Market cap | $6.06M | $8.19M |
| 1-day change | -16.22% | -10.60% |
| EPS (TTM) | $-109.35 | $-5.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $80.70 | $2.20 |
| 52-week low | $4.56 | $0.26 |
| Distance from 52-week high | -94.14% | -62.66% |
| Average volume | 3.68M | 37.12K |
| Shares outstanding | 1.28M | 9.97M |
| Employees | 57 | 175 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Other Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: bioAffinity Technologies in Health Care and XWELL in Consumer Discretionary.
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About XWELL
XWEL stock →XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.
Consumer Discretionary · Other Consumer Services · 175 employees
BIAF vs XWEL FAQ
Which is bigger, bioAffinity Technologies or XWELL?
XWELL (XWEL) is larger, with a market capitalization of $8.19M compared with $6.06M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and XWELL in the same industry?
No. bioAffinity Technologies is in the Health Care sector, while XWELL is in Consumer Discretionary.